Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Genesis Healthcare Inc GENN

Healthcare Medical Care
Genesis Healthcare, Inc. is a holding company. The Company provides services to skilled nursing facilities and assisted/senior living communities. It also specializes in contract rehabilitation therapy, respiratory therapy, physician services, staffing services, and accountable care. It provides approximately 250 skilled nursing centers and senior living communities in 22 states nationwide. Its... see more

Recent & Breaking News (GREY:GENN)

GENESIS HEALTHCARE (GEN) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating Genesis Healthcare, Inc. For Potential Breach of Fiduciary Duty

Business Wire May 16, 2016

Genmab Announces Financial Results for the First Quarter of 2016

GlobeNewswire May 10, 2016

Genesis HealthCare Reports First Quarter 2016 Results

PR Newswire May 9, 2016

Genesis HealthCare Completes Divestiture of Home Health and Hospice Operations

PR Newswire May 2, 2016

Genesis HealthCare To Release First Quarter 2016 Results On May 9, 2016

PR Newswire April 29, 2016

Genmab Announces Daratumumab Data to be Presented at 2016 ASCO Annual Meeting

GlobeNewswire April 20, 2016

Genmab Updates Financial Guidance for 2016

GlobeNewswire April 20, 2016

Genesis Healthcare Names Richard A. Feifer, MD, MPH, FACP As Chief Medical Officer Of Its Physician Subsidiary

PR Newswire April 7, 2016

Patent Infringement Lawsuit Filed Against Genmab and Janssen in the United States Regarding DARZALEX(r)

GlobeNewswire April 4, 2016

CHMP Issues Positive Opinion Recommending DARZALEX(r) (daratumumab) for Relapsed and Refractory Multiple Myeloma

GlobeNewswire April 1, 2016

Genmab Announces Studies of Daratumumab in Combination with Atezolizumab in a Solid Tumor and Multiple Myeloma

GlobeNewswire March 21, 2016

Constitution of the Board of Directors in Genmab A/S and Grant of Warrants to Employees in Genmab

GlobeNewswire March 17, 2016

Genmab Announces Submission of Supplemental Biologics License Application to FDA for Ofatumumab in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL

GlobeNewswire March 10, 2016

Genesis HealthCare to Present at the Barclays Global Healthcare Conference on March 16, 2016

PR Newswire March 10, 2016

Genmab Achieves Second Milestone in Daratumumab NHL Study Under Collaboration with Janssen

GlobeNewswire March 9, 2016

Genmab Announces European Regulatory Submission for Ofatumumab in Combination with Fludarabine and Cyclophosphamide for Relapsed CLL

GlobeNewswire March 9, 2016

Genesis HealthCare Signs Agreement To Sell Home Health And Hospice Operations

PR Newswire March 9, 2016

Genesis HealthCare Reports Fourth Quarter And Fiscal Year End 2015 Results

PR Newswire February 22, 2016

Genesis Healthcare Raises Nearly $255,000 As Gold National Team For Alzheimer's Association Walk To End Alzheimer's®

PR Newswire February 10, 2016

Major Shareholder Announcement

GlobeNewswire February 4, 2016